The 9th International Symposium on Meniere's Disease and Inner Ear Disorders
Abstract Submission

Call for Abstracts
The organizing committee encourages you to contribute to the 9th International Symposium on Meniere's Disease and Inner Ear Disorders. Please submit your abstracts online.
Submission Dates and Deadline
August 25 (noon)  to  November 25 (noon), 2026 (Japan Standard Time, UTC+9)

The system will automatically close at the deadline above. Any modification of the abstracts will not be allowed after the deadline.

Please submit your abstract well in advance. Heavy web access is expected just before the deadline.
This system is optimized for [Firefox] [Google Chrome] [Microsoft Edge] [Safari]. Please don't use other browsers. Using other browsers may cause errors to the saved registration data and such data may possibly NOT be properly stored in the server. Operation with the latest version is assumed.
Submission Number and Password
Upon your abstract submission, you will automatically be assigned a submission number. With this number and your password, you will be able to access your "My page" and revise your registered abstracts any time before the deadline of abstract submission.
You will be responsible for the safekeeping of your password and other confidential information. We strongly urge you to keep a note of your submission number and password. The information is required for confirming your submitted abstract and revising it.
Abstract Submission Guidelines
Registration is strongly recommended before the abstract submission deadline on November 25.
Your registration will be weighed as one of the important factors for the acceptance of your abstract(s).
A maximum of three abstract submissions per person is allowed.
Abstracts must be submitted via this website only. Abstracts submitted by fax or e-mail will not be accepted.
Abstracts must be received by the stated deadline. Abstracts received after the deadline will not be considered.
All abstracts MUST be submitted in ENGLISH.
The Presenting Author must be the First (submitting) Author with his or her name appearing first in the abstract.
The abstract body should be no more than 1,800 characters (approximately 300 words), and the title should be within 150 characters, including spaces.
The authors are responsible for checking mistakes in literature or in scientific facts.
All submitted abstracts will be forwarded to the Committee for review. Notifications regarding status will be sent once the review process is completed.
Authors may choose to submit for either oral or poster presentations, but please note the final decision including presentation date & time will be made by the President and Program Committee.
You will receive confirmation that your abstract has been received, indicating the abstract number which it has been allocated. Please refer to this Submission number in all correspondence regarding the abstract.
If there is a change in presenting author, the conference organizers must be informed in advance.
If the presenting author has not registered, the acceptance will be withdrawn.
When submitting an abstract, you can set your own password.
After you complete the submission, you will automatically be assigned a registration number.
Please keep your registration number and password until the meeting. These are necessary to confirm/modify/cancel your abstract.
For security purposes, we are unable to answer any questions about passwords.
Before the due date, confirmation and correction can be made repeatedly by inputting the submission number and password.
Presentation Style
Oral / Poster

Please note the final decision including presentation date & time will be made by the President and Program Committee.
Abstract Topics
01. Basic Science 06. Inner Ear Disease
02. Genetics 07. Central Disease
03. Imaging (CT, MRI) 08. Diagnosis
04. Vestibular / Audiological Testing 09. Others
05. Treatment (including Cochlear Implant)  
Preparing Your Abstract Submission

First and Co-authors: 20 authors or less

Affiliation/ Institutions: 10 affiliations/institutions or less

Abstract Title: 150 characters including spaces

Abstract Body: 1,800 characters (approx. 300 words) including spaces

If the character limit is exceeded, submission will not be completed.

Do not include author's information such as affiliation and title in the abstract body area.
Please refrain from using platform-dependent characters.

Acceptable structure of an abstract must consist of four components: Background/Aim, Methods, Results and Conclusion.

Only one TABLE, GRAPH, or IMAGE may be submitted.

The maximum file size of each graph/image is 500KB and JPG format is recommended.

You may change or revise your abstract before deadline Noon November 25, 2026 (Japan Standard Time, UTC+9)

If you want to include symbols or Greek Letters, type the respective code indicated in the tables at the position where you want to place it, or copy the code and paste it in the position.

You Type α β γ δ ε ζ η θ ι κ ç
Display α β γ δ ε ζ η θ ι κ ç
You Type λ μ ν ξ ο π ρ σ τ υ Ç
Display λ μ ν ξ ο π ρ σ τ υ Ç
You Type φ χ ψ ω © ® ™ ± < > ≠
Display φ χ ψ ω © ® ™ ± < > ≠

If you want to use superscripts, subscripts, italics, bold, or underlines, follow the instructions below.

Superscripts: Enclose the text between <sup> and </sup>.

 For example, Na<sup>+</sup> → Na+.

Subscripts: Enclose the text between <sub> and </sub>.

 For example, H<sub>2</sub>O → H2O.

Italics: Enclose the text between <i> and </i>.

 For example, <i>c-fos</i> → c-fos.

Bold: Enclose the text between <b> and </b>.

 For example, <b>accent</b> → accent.

Underlines: Enclose the text between <u> and </u>.

 For example, <u>directly</u> → directly.

If you want to start a new line, put <br> in the front of the sentence.

Please refer to the FAQ pages before submitting an inquiry.
Notification of Acceptance
Notification of registration confirmation will be sent to the registered e-mail address. If you do not receive a notification at the registered e-mail address within 1-2 days, please inform the Conference Secretariat.
Personal Information Protection
"Names" and "contact addresses" provided to us for Abstract Submission for the conference shall be used for the purpose of contact from the secretariat, notification of acceptance or rejection, and any information related to the presentation. In addition, the "presenters' names," "affiliation names," "title" and "abstract text" shall be used for publication in the program/proceedings and on the website, but not for other purposes.
Abstract submission has been commissioned to c/o MediProduce, Inc. in order to facilitate operations management.
As a Congress Secretariat of the 9th International Symposium on Meniere's Disease and Inner Ear Disorders, MediProduce, Inc., shall handle personal information in accordance to its Privacy Policy and ensure proper management.
Congress Secretariat
E-mail: meniere2027@mediproduce.com
Abstract Submission System